Physician profile
Ashley E Lay
NPI 1265188940
$5,114.90
in general payments reported to CMS, 2019-2025
45 companies · $2,057 in 2025
The $2,057 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.72 · 2022: $1,913 · 2023: $865 · 2024: $252 · 2025: $2,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Education: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.34 |
| Education | $788.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $692.19 | 2022-2025 | Tagrisso, Lynparza, Calquence |
| Janssen Biotech, INC. | $571.19 | 2022-2025 | Talvey, Darzalex, Tecvayli |
| Astellas Pharma US INC | $526.52 | 2025 | Padcev, Xtandi |
| Lilly USA, LLC | $322.16 | 2022-2023 | Verzenio, Jaypirca, Retevmo |
| Incyte Corporation | $294.47 | 2022-2025 | Monjuvi, Niktimvo, Jakafi |
| Novartis Pharmaceuticals Corporation | $206.09 | 2023-2025 | Piqray, Kisqali |
| Aveo Pharmaceuticals, INC. | $177.06 | 2022-2025 | Fotivda |
| Takeda Pharmaceuticals U.S.A., INC. | $171.86 | 2022-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Celgene Corporation | $165.83 | 2022-2023 | Onureg |
| Eisai INC. | $135.81 | 2022-2024 | |
| Glaxosmithkline, LLC. | $131.16 | 2022-2025 | Blenrep, Ojjaara |
| E.R. Squibb & Sons, L.L.C. | $121.67 | 2025 | Opdivo |
| Emd Serono, INC. | $115.15 | 2022-2023 | Bavencio |
| Pfizer INC. | $108.16 | 2022-2024 | |
| Daiichi Sankyo INC. | $107.22 | 2022-2025 | Enhertu |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.